Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

Title
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 31, Issue 12, Pages 1296-1309
Publisher
Wiley
Online
2010-05-24
DOI
10.1111/j.1365-2036.2010.04304.x

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search